This compound is widely used in bioconjugation and protein labeling due to its maleimide group, which reacts selectively with thiol groups (-SH) in cysteine residues. It is particularly valuable in the development of antibody-drug conjugates (ADCs), where it serves as a linker to attach cytotoxic drugs to antibodies, enabling targeted cancer therapy. Additionally, it is employed in the modification of peptides, proteins, and other biomolecules for research and diagnostic purposes. Its cyclohexane backbone provides stability, making it suitable for applications requiring robust chemical structures.